Goldman Sachs Group Inc Vericel Corp Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 201,204 shares of VCEL stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
201,204
Previous 153,462
31.11%
Holding current value
$11.9 Million
Previous $7.04 Million
20.74%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding VCEL
# of Institutions
276Shares Held
48.4MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$476 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$226 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$206 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$144 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$140 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.79B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...